Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032

Core Viewpoint - Tandem Diabetes Care, Inc. has announced the pricing of $265.0 million in aggregate principal amount of 0.00% Convertible Senior Notes due 2032 in a private placement aimed at qualified institutional buyers under Rule 144A of the Securities Act [1] Group 1 - The offering of the convertible senior notes was upsized from a previously announced amount [1]